Serum level of lipoprotein-associated phospholipase A2 is a potential biomarker of vertebrobasilar dolichoectasia and its progression to cerebral infarction.

Yuan LiuJinhua ZhuXuhui DengZhi YangChunchun ChenShuxuan HuangLue ChenYing MaWeifeng LinFeiqi Zhu

Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2020)

The serum marker Lp-PLA2 is an independent risk factor for the occurrence of VBD and the progression of VBD to posterior circulation ischemic stroke. Whether intervening on atherosclerosis could prevent the occurrence and development of VBD needs to be further studied.

Keyphrases

risk assessment
cardiovascular disease
atrial fibrillation
type diabetes
endovascular treatment
solid state